Educational intervention for rural patients with early stage cancer
Patient-Centered Video Education Intervention to Improve Rural Cancer Care Delivery in Vermont: A Feasibility Study
This study is testing whether a video education program can help rural patients with early stage breast, lung, or colon cancer better understand their care and feel more confident during their treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Vermont Medical Center Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Burlington, Vermont) |
| Trial ID | NCT05723250 on ClinicalTrials.gov |
What this trial studies
This study aims to improve care coordination for cancer patients from rural areas by providing a video educational intervention. Patients diagnosed with early stage breast, lung, or colon cancer will be randomized to receive this educational tool either before or after starting their adjuvant therapy. The study will assess changes in patients' knowledge about cancer, self-advocacy, and their perception of care coordination over a period of 4-6 months. The goal is to enhance the overall experience and outcomes for these patients during their treatment.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older with early stage breast, lung, or colon cancer living in rural Vermont.
Not a fit: Patients with a history of prior malignancy treated with chemotherapy in the last 3 years or those residing in Chittenden County may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve patients' understanding of their care and enhance their ability to advocate for themselves.
How similar studies have performed: While there is limited data on similar educational interventions specifically for rural cancer patients, previous studies have shown that educational tools can improve patient outcomes in various healthcare settings.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18+ years of age * Breast, lung, or colon cancer diagnosis * Stage I, II or III cancer * Adjuvant chemotherapy started \< 30 days or planned within the next 30 days * Rural residence location in Vermont (outside Chittenden County) * Proficient in English Exclusion Criteria: * History of prior malignancy treated with chemotherapy in last 3 years * Known or suspected neuro-cognitive impairment * Resident of Chittenden County, Vermont * Patients with current diagnosis other than stage I, II or III breast, colon or lung cancer
Where this trial is running
Burlington, Vermont
- University of Vermont Cancer Center — Burlington, Vermont, United States (Recruiting)
Study contacts
- Study coordinator: Randall F Holcombe
- Email: randall.holcombe@med.uvm.edu
- Phone: 18026563812
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.